SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-156039
Filing Date
2018-05-08
Accepted
2018-05-08 16:29:43
Documents
52
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d575503d10q.htm 10-Q 609115
2 EX-31.1 d575503dex311.htm EX-31.1 6285
3 EX-31.2 d575503dex312.htm EX-31.2 6280
4 EX-32.1 d575503dex321.htm EX-32.1 3745
5 EX-32.2 d575503dex322.htm EX-32.2 3721
  Complete submission text file 0001193125-18-156039.txt   2260712

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dcph-20180331.xml EX-101.INS 248077
7 XBRL TAXONOMY EXTENSION SCHEMA dcph-20180331.xsd EX-101.SCH 30030
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dcph-20180331_cal.xml EX-101.CAL 39157
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dcph-20180331_def.xml EX-101.DEF 86023
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dcph-20180331_lab.xml EX-101.LAB 235285
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dcph-20180331_pre.xml EX-101.PRE 164056
Mailing Address 500 TOTTEN POND ROAD WALTHAM MA 02451
Business Address 500 TOTTEN POND ROAD WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38219 | Film No.: 18815052
SIC: 2834 Pharmaceutical Preparations